Has Martha Tonzi received payments from drug or device companies?

Yes. Drug and device makers reported $4,982 in general payments to Martha Tonzi across 238 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Martha Tonzi did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Martha Tonzi come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Martha Tonzi

Gastroenterology · Milford, MANPI 1477649507

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.0% of the total across 238 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by AbbVie at 37.7% of the total. Reporting peaked in 2022 at $1,908 and has fallen 97.6% since, to $46 in 2025.

$4,982in general payments, 2019–2025

Across 238 payments — averaging $20.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$2K
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$991
Gilead$513
Braintree Laboratories, Inc.$286
Nestle Healthcare Nutrition Inc.$178
Takeda Pharmaceuticals U.S.A., Inc.$140
plus $994 from 15 others

What the payments were for

Food & beverage$4,88398%
Education$501%
Gifts$481%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	87	$1,880
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	45	$991
Gilead	20	$513
Braintree Laboratories, Inc.	29	$286
Nestle Healthcare Nutrition Inc.	8	$178
Takeda Pharmaceuticals U.S.A., Inc.	7	$140
Pfizer	6	$140
Ferring Pharmaceuticals Inc.	5	$131
Bristol Myers Squibb	7	$128
Intercept Pharmaceuticals, Inc.	5	$117
Johnson & Johnson	4	$85
Fujifilm Healthcare Americas Corporation	2	$65
Sanofi	2	$62
Ironwood Pharmaceuticals, Inc	2	$54
Redhill Biopharma Inc.	3	$52
E.r. Squibb & Sons, L.L.C.	1	$45
Regeneron Healthcare Solutions, Inc.	1	$34
Daiichi Sankyo Inc.	1	$26
Endo Pharmaceuticals Inc.	1	$24
Capsovision, Inc.	1	$16
Amgen	1	$15

How this compares

$4,982 in reported general payments places this provider in the 75th percentile of 579 gastroenterology providers in Massachusetts.

See all gastroenterology providers in Massachusetts →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Omeprazole	18	$181
Pantoprazole Sodium	12	$114

Paid to pharmacies, not to this prescriber.

Other gastroenterology in Milford

Hiroyuki AiharaBoston$728K
Jessica AllegrettiBoston$696K
John LeungBoston$682K
Ramnik XavierBoston$567K
Adam CheifetzBoston$512K
Carlo TraversoBoston$447K
Razvan ArsenescuMedford$385K
Steven FineFramingham$259K
Tyler BerzinBoston$215K
Khaldoon KhirfanBurlington$167K

See the full list for Massachusetts →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →